Last reviewed · How we verify
NCT07143851
Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases
trial testing Not applicable- observational study in Retina Disease in 5,000 participants. Not yet recruiting.
30 June 2028
Quick facts
| Lead sponsor | Beijing Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 30 August 2025 |
| Primary completion | 30 June 2028 |
| Estimated completion | 30 June 2028 |
Drugs / interventions tested
- Not applicable- observational study — full drug profile →
Conditions studied
- Retina Disease — all drugs for Retina Disease →
- Glaucoma — all drugs for Glaucoma →
Sponsor
Beijing Hospital
Who can join
Adults 20 to 90, any sex, with Retina Disease or Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aiming at the problems of low image reading efficiency, crowded medical resources and fragmented cross-modal information of ophthalmic OCT and OCTA, a multimodal large model diagnostic framework for various diseases such as retinal diseases and optic nerve damage in glaucoma is constructed to fully explore the complementary information of various images such as SS-OCT structural images, SS-OCTA vascular images and optic nerve scans. Extract cross-modal joint features to improve the accuracy of automatic diagnosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07143851
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Not applicable- observational study
Trials testing the same drug.
- NCT07518433 — Study on Serum Transcriptomics and Metabolomics in Patients With Diabetic Peripheral Neuropathy · not yet recruiting
- NCT07416760 — Analysis of the Composition of the Intestinal Microbiota in Patients Post-intestinal Anastomosis · recruiting
- NCT07422584 — Cytokine Response to Abdominal Wall Reconstruction · recruiting
- NCT07260617 — Association Between Composition of the Gut Microbiota and Nutritional Status in Digestive Oncology · not yet recruiting
- NCT07178626 — Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients · enrolling by invitation
Other Beijing Hospital trials
Trials by the same sponsor.
- NCT07523724 — Screening and Management of Adults With Asthma and Allergic Diseases · NA · not yet recruiting
- NCT07398430 — Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea · not yet recruiting
- NCT07295665 — External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease · not yet recruiting
- NCT06955819 — GUTPROH: Probiotic-Herbal Formula for Self-Reported Constipation in Community Adults · NA · not yet recruiting
- NCT06703671 — Electroacupuncture Treatment for Discogenic Low Back Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07143851 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Hospital
- Last refreshed: 27 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07143851.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing